KTSDITQARVKSC, corresponding to C terminal amino acids 337-349 of Human IRF2.
Our Abpromise guarantee covers the use of ab3388 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 1 - 3 µg/ml. Detects a band of approximately 45 kDa (predicted molecular weight: 38 kDa).Can be blocked with Human IRF2 peptide (ab22943). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Li et al, Invest Ophthalmol Vis Sci. 1999 Apr;40(5):976-82.; PMID: 10102295.|